VMP 36061811000001100

Search dm+d | This VMP cannot be matched against our prescribing data.

Name Galsulfase 5mg/5ml solution for infusion vials
BNF code 0908010AGAAAAAA
Virtual Therapeutic Moiety Galsulfase
Date identifier became valid 30 Oct 2018
Previous product identifier 419538005
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 19 Jan 2009
Previous name Galsulfase 5mg/5ml solution for injection vials
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 5.000
Unit dose form units ml
Unit dose unit of measure vial
Virtual Product Ingredient
Ingredient Galsulfase
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 1.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route solutioninfusion.intravenous
Dose Form
Formulation Solution for infusion
Drug Route
Route Intravenous
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Naglazyme 5mg/5ml solution for infusion vials (BioMarin (U.K.) Ltd)
Virtual Medicinal Product Packs
Galsulfase 5mg/5ml solution for infusion vials 1 vial

dm+d data retrieved from TRUD: release NHSBSA_9.3.0_20240923000001, imported on 23rd September 2024 at 04:57:49.

Feedback